Cargando…
The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain
Clinical trials of rotigotine extended-release microspheres (RTGT-MS), which provides a sustained release of rotigotine for near 2 weeks in vivo, have been conducted in the treatment of Parkinson’s disease (PD). This study was to investigate the analgesic effect of RTGT-MS, and to know whether RTGT-...
Autores principales: | Li, Keke, Zhang, Yijia, Tian, Enming, Liu, Zikai, Wang, Tian, Fu, Fenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663167/ https://www.ncbi.nlm.nih.gov/pubmed/33192533 http://dx.doi.org/10.3389/fphar.2020.594387 |
Ejemplares similares
-
Dopamine receptor agonist rotigotine-loaded microspheres ameliorates sexual
function deteriorated by fluoxetine in depression rats
por: Wang, Wenqian, et al.
Publicado: (2021) -
Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats
por: Yutong, Mao, et al.
Publicado: (2023) -
Safety of liposome extended-release bupivacaine for postoperative pain control
por: Portillo, Juan, et al.
Publicado: (2014) -
The Effect of Once-Daily Gabapentin Extended Release Formulation in Patients With Postamputation Pain
por: Knezevic, Nebojsa Nick, et al.
Publicado: (2019) -
Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in “de-novo” Parkinsonian subjects: a randomized controlled trial with 18-month follow-up
por: Ferrazzoli, D., et al.
Publicado: (2018)